Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: anALWP/EBMTanalysis-Reference-Cited by-同舟云学术

Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: anALWP/EBMTanalysis

Published:2018-11-16 Issue:4 Volume:285 Page:407-418
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Canaani J.¹^ORCID,Beohou E.²,Labopin M.²,Ghavamzadeh A.³,Beelen D.⁴,Hamladji R.‐M.⁵,Niederwieser D.⁶,Volin L.⁷,Markiewicz M.⁸,Arnold R.⁹,Mufti G.¹⁰,Ehninger G.¹¹,Socié G.¹²,Kröger N.¹³,Mohty M.²,Nagler A.¹²

Affiliation:

1. Hematology Division Chaim Sheba Medical Center Tel Aviv University Tel‐Hashomer Israel

2. Acute Leukemia Working Party –EBMT and Department of Hematology and Cell Therapy Hȏpital Saint‐Antoine Paris France

3. Hematology‐Oncology and BMT Research Shariati Hospital Teheran Iran

4. Department of Bone Marrow Transplantation University Hospital Essen Germany

5. Service Hématologie Greffe de Moëlle Centre Pierre et Marie Curie Alger Algeria

6. Division of Haematology & Oncology University Hospital Leipzig Leipzig Germany

7. Stem Cell Transplantation Unit Comprehensive Cancer Centre Helsinki University Hospital Helsinki Finland

8. Department of Haematology and BMT Medical University of Silesia Katowice Poland

9. Medizinische Klinik m. S. Hämatologie/Onkologie Charité Universitaetsmedizin Berlin Berlin Germany

10. Department of Haematological Medicine GKT School of Medicine London UK

11. Universitaetsklinikum Dresden Medizinische Klinik und Poliklinik I Dresden Germany

12. Department of Hematology – BMT Hȏpital St. Louis Paris France

13. Bone Marrow Transplantation Centre University Hospital Eppendorf Hamburg Germany

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/joim.12854

Reference41 articles.

1. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis‐related death in allogeneic marrow transplant recipients: long‐term follow‐up of a randomized, placebo‐controlled trial;Marr KA;Blood,2000

2. Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective

3. Efficacy of a Viral Load-Based, Risk-Adapted, Preemptive Treatment Strategy for Prevention of Cytomegalovirus Disease after Hematopoietic Cell Transplantation

4. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases

5. Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Adult Acute Myeloid Leukemia: Outcomes and Prognostic Factors;Transplantation and Cellular Therapy;2024-09

2. Trends in allogeneic transplantation for favorable risk acute myeloid leukemia in first remission: a longitudinal study of >15 years from the ALWP of the EBMT;Bone Marrow Transplantation;2024-08-20

3. Comparison of Older Related versus Younger Unrelated Donors for Older Recipients of Allogeneic Hematopoietic Cell Transplantation with Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Large Single-Center Analysis;Transplantation and Cellular Therapy;2024-07

4. Comparison of Allogeneic Transplant Outcomes Between Matched Sibling Donors and Alternative Donors in Patients Over 50 Years of Age with Acute Myeloid Leukemia: 8/8 Allele-Matched Unrelated Donors and Unrelated Cord Blood Provide Better Leukemia-Free Survival Compared with Matched Sibling Donors During Nonremission Status;Transplantation and Cellular Therapy;2024-02

5. Comparison of fludarabine‐based conditioning regimens in adult cord blood transplantation for myeloid malignancy: A retrospective, registry‐based study;American Journal of Hematology;2024-01-02